Cover Caption
About the cover: Silibinin treatment enhances E-cadherin and down-modulates Zeb1 expression in NSCLC H322 and H358 cells. See the article by Mateen et al. on page 206 of this issue.
In this issue
Jump to
- Highlighted Papers
- Cardiovascular
- Cellular and Molecular
- Chemotherapy, Antibiotics, and Gene Therapy
- Drug Discovery and Translational Medicine
- Endocrine and Diabetes
- Gastrointestinal, Hepatic, Pulmonary, and Renal
- Inflammation, Immunopharmacology, and Asthma
- Metabolism, Transport, and Pharmacogenomics
- Neuropharmacology
- Errata
